Shotlee LogoShotlee
Blog
Download on theApp Store
Become aBeta Tester
Skip to main content
More UK Men Using Weight Loss Injections as 'Significant Shift' Emerges - Featured image
Health

More UK Men Using Weight Loss Injections as 'Significant Shift' Emerges

Recent research highlights a growing trend of British men turning to weight loss injections. Data indicates a significant shift in usage, with men increasingly adopting these treatments.

Shotlee·December 13, 2025·Updated Jan 27, 2026·3 min read
Share:

More UK Men Using Weight Loss Injections as 'Significant Shift' Emerges

New research has revealed an increasing number of British men are opting for fat jabs in order to lose weight. Previously, women significantly outnumbered men in the use of these injections, but a major prescriber of these medications reports that men are catching up.

Chemist4u data indicates a shift from a 90% female to 10% male ordering ratio, to a current split of 60% female and 40% male. James O'Loan, CEO of Chemist4U, noted increasing evidence of men prioritizing their health, citing examples such as taxi drivers seeking treatment during business trips.

According to O'Loan, one individual was unable to undergo a hernia operation due to being overweight, but has now been able to have the procedure following weight loss. He added that men might be less inclined to discuss their health, possibly due to social taboos or discomfort. However, he emphasized that a brilliant shift is definitely becoming apparent.

GLP-1 medications function by mimicking a natural hormone, which helps to manage type 2 diabetes. These medications also aid in weight loss by both slowing digestion and suppressing appetite. Health tracking apps like Shotlee can help monitor the progress and effects of such treatments.

Track your medication journey

Join thousands using Shotlee to track GLP-1 medications.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store
Become aBeta Tester

The number of NHS prescriptions has increased to 280 per hour, with a total of 201,686 prescriptions issued in September for one popular injection. Furthermore, an estimated 1.4 million individuals in the UK are believed to have self-funded their weight loss endeavors.

O'Loan stated that the momentum surrounding these new obesity treatments is building, creating a sense of excitement. He believes that these treatments have instilled confidence in individuals where previous methods have failed.

However, while these injections can provide a convenient solution for weight loss, some users have reported experiencing adverse effects. For example, singer Robbie Williams attributed his gradual vision loss to weight loss injections like Mounjaro. He reported that, despite being prescribed the medication for rapid weight gain, he believed the injections were causing his eyesight to deteriorate rapidly.

Williams described his vision problems, saying that players at a football game appeared as blobs and that he couldn't clearly see female fans during his concerts. Despite his sight loss, Williams admitted the injections were so effective that he would continue using them until he lost sight in one eye. He is now among over 300 cases reported to authorities regarding gradual sight loss potentially caused by Mounjaro.

Original source: Daily Star

View original article →
#weight loss#fat jabs#men's health#GLP-1 medications#obesity treatments
  1. Home
  2. Blog
  3. More UK Men Using Weight Loss Injections as 'Significant Shift' Emerges

Related Articles

Millennial Stars Admit to Ozempic & GLP-1 Use: Transformations
GLP-1 Medications

Millennial Stars Admit to Ozempic & GLP-1 Use: Transformations

Midlife weight gain is hitting millennial stars hard, but many are turning to Ozempic and other GLP-1s for help. Celebrities including Amy Schumer, Golnesa 'GG' Gharachedaghi, and Serena Williams have openly admitted to using these medications, sharing their triumphs, side effects, and transformations. Discover their stories and the science behind these popular drugs.

SNAC in Ozempic and Wegovy Tablets Raises Gut Health Questions, Study Finds
GLP-1 Medications

SNAC in Ozempic and Wegovy Tablets Raises Gut Health Questions, Study Finds

New research uncovers potential effects of SNAC—the hidden ingredient enabling Ozempic and Wegovy tablets—on gut health. In a 21-day animal study, repeated exposure led to shifts in harmful gut bacteria, elevated inflammation, and depleted cognitive proteins. While not proving harm in humans, findings urge caution as oral semaglutide use surges.

73M Overweight Urban Indians, GLP-1 Awareness <5%: Kantar Report
Metabolic Health

73M Overweight Urban Indians, GLP-1 Awareness <5%: Kantar Report

Urban India faces a metabolic crisis with 73 million overweight adults, yet GLP-1 therapy awareness hovers below 5%, per Kantar's latest report. Despite high weight loss intent, a stark knowledge gap limits adoption of these diabetes and obesity treatments. Explore the data, demographics, and paths forward for better metabolic health.

Shotlee LogoShotlee

Your comprehensive health tracking companion. Track, analyze, and optimize your journey with advanced metrics and community support.

Product

  • Get Started

Resources

  • Health Blog
  • Support Center
  • System Status

Legal

  • Privacy Policy
  • Terms of Service
  • Community Guidelines
  • Refund Policy

© 2026 Shotlee. All rights reserved.

Made with ♥ for the community